Income Statement
CONCENTRIX CORP
CNXC
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Nov 30, 2025 2025 FY | Nov 30, 2024 2024 FY | Nov 30, 2023 2023 FY | Nov 30, 2022 2022 FY | Nov 30, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
9,825.77 | 9,618.90 | 7,114.71 | 6,324.47 | 5,587.02 |
|
Cost of Revenue
|
6,390.76 | 6,170.01 | 4,536.77 | 4,067.21 | 3,617.53 |
|
Gross Profit
|
3,435.01 | 3,448.89 | 2,577.94 | 2,257.26 | 1,969.49 |
|
Operating Expenses
|
2,825.47 | 2,852.50 | 1,916.61 | 1,617.07 | 1,397.09 |
|
Research & Development
|
- | - | - | - | - |
|
Selling, General & Administrative
|
2,825.47 | 2,852.50 | 1,916.61 | 1,617.07 | 1,397.09 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
609.54 | 596.39 | 661.33 | 640.19 | 572.40 |
|
Non-Operating Income
|
1,791.77 | 297.11 | 253.10 | 35.19 | 16.70 |
|
Interest Income
|
- | - | - | - | - |
|
Interest Expense
|
- | - | - | - | - |
|
Other Non-Op Income / Expense
|
26.31 | 24.72 | -52.10 | 34.89 | 6.35 |
|
Income Before Tax
|
-1,182.22 | 299.27 | 408.23 | 605.00 | 555.70 |
|
Income Tax Expense
|
96.70 | 48.06 | 94.39 | 169.95 | 150.12 |
|
Non-Controlling Interest
|
- | 0.00 | 0.00 | 0.59 | - |
|
Net Income
|
-1,278.92 | 251.22 | 313.84 | 435.05 | 405.58 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Nov 30, 2025 2025 FY | Nov 30, 2024 2024 FY | Nov 30, 2023 2023 FY | Nov 30, 2022 2022 FY | Nov 30, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
609.54 | 596.39 | 661.33 | 640.19 | 572.40 |
|
Earnings Per Share (Basic)
|
-20.36 | 3.72 | 5.72 | 8.34 | 7.78 |
|
Diluted EPS
|
-20.36 | 3.71 | 5.70 | 8.28 | 7.70 |
|
Weighted Average Shares
|
63.01 | 64.98 | 53.80 | 51.35 | 51.36 |
|
Diluted Weighted Avg Shares
|
63.01 | 65.07 | 54.01 | 51.74 | 51.91 |
|
Comprehensive Income
|
- | 28.63 | 437.86 | 189.83 | 338.87 |